CSIMarket
 


Pulmatrix Inc   (PULM)
Other Ticker:  
 

Cumulative Pulmatrix Inc 's Quick Ratio for Trailing Twelve Months Period

PULM's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PULM Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -12.18 % -16.93 % -26.48 % -6.24 % 19.11 %
Y / Y Cash & cash equivalent Growth -47.75 % -40.1 % -35.3 % -33.54 % -23.66 %
Quick Ratio for Trailing Twelve Months Period 7.2 8.12 8.82 9.05 9.88
Total Ranking # 468 # 496 # 499 # 501 # 640
Seq. Current Liabilities Growth 36.74 % -18.06 % -5.09 % -17.41 % 29.34 %
Seq. Cash & cash equivalent Growth -17.27 % -16.14 % -14.05 % -12.38 % -5.16 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite year on year decrease in Pulmatrix Inc 's average Current Liabilities to $4 millions, Quick Ratio for Trailing Twelve Months Period to 7.2 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 307 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Pulmatrix Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about PULM
Quick Ratio PULM in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 308
Sector # 499
S&P 500 # 850


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.69 4.05 0.89
(Mar 31 2022)   (Sep 30 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Kura Oncology Inc   19.60 
Nuvalent Inc   18.90 
Keros Therapeutics Inc   18.68 
Day One Biopharmaceuticals Inc   18.66 
Lantern Pharma Inc   18.27 
Stoke Therapeutics Inc   17.90 
Lixte Biotechnology Holdings Inc   17.72 
Viking Therapeutics Inc   17.51 
Cymabay Therapeutics Inc   17.11 
Immuneering Corporation  17.10 
Acrivon Therapeutics Inc   17.03 
Cohbar Inc   16.98 
Akouos inc   16.79 
Structure Therapeutics Inc   16.67 
Pliant Therapeutics Inc   16.55 
Pasithea Therapeutics Corp   16.53 
Agios Pharmaceuticals Inc   16.47 
Pardes Biosciences Inc   16.28 
Anixa Biosciences Inc   16.18 
Medicinova Inc   16.15 
Iveric Bio Inc   16.08 
Lipocine Inc   16.04 
Nanoviricides inc   16.02 
Fulcrum Therapeutics Inc   15.92 
Sagimet Biosciences inc   15.69 
Lyell Immunopharma Inc   15.60 
Verve Therapeutics Inc   15.59 
Artelo Biosciences Inc   15.20 
Ovid Therapeutics Inc   15.10 
Ideaya Biosciences Inc   14.94 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com